OBJECTIVES: To investigate the survival-related factors of patients with advanced stage ovarian cancer who underwent debulking surgery after neoadjuvant chemotherapy (NAC)
Aim: To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the f...
Primary treatment of patients with advanced epithelial ovarian cancer consists of chemotherapy eithe...
Objective: The main purpose of the study is to determine the survival and death rate of the female a...
In Denmark, the proportion of women with ovarian cancer treated with neoadjuvant chemotherapy (NACT)...
The aim of this study was to evaluate the role of neoadjuvant chemotherapy (NACT) in advanced ovaria...
OBJECTIVES: Complete surgery with no macroscopic residual disease (RD) at primary (PDS) or interval ...
The aim of this study was to compare the outcome of patients with advanced ovarian carcinoma treated...
The aim of this study is to evaluate the effects on survival outcomes of the disease burden before i...
Objective: Neoadjuvant chemotherapy plus interval debulking surgery is growing treatment strategy fo...
International audienceIntroduction The aim of this study was to identify prognostic factors of overa...
OBJECTIVE: The objective of the study was to analyze in a large series of unresectable advanced ovar...
Introduction: To compare long-term survival of primary debulking surgery (PDS) and interval debulkin...
ObjectivesWe performed a patterns-of-care study to characterize the types of patients with epithelia...
Objective: It is known that optimal or complete cytoreduction is the most important factor in patien...
chemotherapy in ovarian cancer patients with extensive tumor burden To the editor: I read with great...
Aim: To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the f...
Primary treatment of patients with advanced epithelial ovarian cancer consists of chemotherapy eithe...
Objective: The main purpose of the study is to determine the survival and death rate of the female a...
In Denmark, the proportion of women with ovarian cancer treated with neoadjuvant chemotherapy (NACT)...
The aim of this study was to evaluate the role of neoadjuvant chemotherapy (NACT) in advanced ovaria...
OBJECTIVES: Complete surgery with no macroscopic residual disease (RD) at primary (PDS) or interval ...
The aim of this study was to compare the outcome of patients with advanced ovarian carcinoma treated...
The aim of this study is to evaluate the effects on survival outcomes of the disease burden before i...
Objective: Neoadjuvant chemotherapy plus interval debulking surgery is growing treatment strategy fo...
International audienceIntroduction The aim of this study was to identify prognostic factors of overa...
OBJECTIVE: The objective of the study was to analyze in a large series of unresectable advanced ovar...
Introduction: To compare long-term survival of primary debulking surgery (PDS) and interval debulkin...
ObjectivesWe performed a patterns-of-care study to characterize the types of patients with epithelia...
Objective: It is known that optimal or complete cytoreduction is the most important factor in patien...
chemotherapy in ovarian cancer patients with extensive tumor burden To the editor: I read with great...
Aim: To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the f...
Primary treatment of patients with advanced epithelial ovarian cancer consists of chemotherapy eithe...
Objective: The main purpose of the study is to determine the survival and death rate of the female a...
DOI
Add to ORKG